The curability of tumours of differing size by targeted radiotherapy using 131I or 90Y

This publication has 20 references indexed in Scilit:

• A pilot study of131I monoclonal antibodies in the therapy of leptomeningeal tumors
  Cancer, 1988
• The biodistribution and pharmacokinetics of meta-iodobenzylguanidine in childhood neuroblastoma
  European Journal of Nuclear Medicine and Molecular Imaging, 1988
• Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies.
  Journal of Clinical Oncology, 1987
• 131-metaiodobenzylguanedine therapy of neuroblastoma in childhood
  European Journal of Pediatrics, 1987
• Therapeutic use of ¹³¹I‐metaiodobenzylguanidine (MIBG) in neuroblastoma: A phase II study in nine patients
  Medical and Pediatric Oncology, 1987
• ANTIBODY-GUIDED RADIATION THERAPY VIA THE CSF FOR MALIGNANT MENINGITIS
  The Lancet, 1986
• 131-I Coupled to Monoclonal Antibodies as Therapeutic Agents for Neuroectodermally Derived Tumors: Fact or Fiction?
  Cancer Drug Delivery, 1986
• Phase I–II study of radiolabeled antibody integrated in the treatment of primary hepatic malignancies
  International Journal of Radiation Oncology*Biology*Physics, 1980
• The statistics of dose/cure relationships for irradiated tumours. Part I.
  The British Journal of Radiology, 1980
• The Relation Between Tumour Lethal Doses and the Radiosensitivity of Tumour Cells
  The British Journal of Radiology, 1961